Valantine Hannah sold BBIO

November 12, 2025 · Form 4 insider transaction

Valantine Hannah sold 25,484 shares of BridgeBio Pharma, Inc. at $66.07 per share, a transaction worth $1.68M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.